Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 4,131 | 1,517 | 268 | 967 | 1,613 |
| Gross Profit | 4,131 | 1,517 | 268 | 967 | 1,613 |
| Operating Expenses | 51,758 | 42,756 | 33,473 | 33,438 | 29,498 |
| Operating Income | -47,627 | -41,239 | -33,205 | -32,471 | -27,885 |
| Other Income | 4,321 | 2,979 | 2,703 | 3,110 | 1,398 |
| Pre-tax Income | -43,306 | -38,260 | -30,502 | -29,361 | -26,487 |
| Net Income Continuous | -43,306 | -38,260 | -30,502 | -29,361 | -26,487 |
| Net Income | $-43,306 | $-38,260 | $-30,502 | $-29,361 | $-26,487 |
| EPS Basic Total Ops | -0.84 | -0.81 | -0.65 | -0.62 | -0.57 |
| EPS Basic Continuous Ops | -0.84 | -0.81 | -0.65 | -0.62 | -0.56 |
| EPS Diluted Total Ops | -0.84 | -0.81 | -0.65 | -0.62 | -0.57 |
| EPS Diluted Continuous Ops | -0.84 | -0.81 | -0.65 | -0.62 | -0.56 |
| EBITDA(a) | $-49,047 | $-42,099 | $-33,609 | $-33,001 | $-27,734 |